Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001340243-23-000030
Filing Date
2023-07-28
Accepted
2023-07-28 06:31:44
Documents
14
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 6-K a230728_6kxmorxvotingright.htm 6-K 12995
2 EX-99.1 exhibit-991.htm EX-99.1 6617
3 EX-99.2 exhibit-992.htm EX-99.2 6233
4 GRAPHIC exhibit-991001.jpg GRAPHIC 130994
5 GRAPHIC exhibit-991002.jpg GRAPHIC 119076
6 GRAPHIC exhibit-991003.jpg GRAPHIC 118969
7 GRAPHIC exhibit-991004.jpg GRAPHIC 92218
8 GRAPHIC exhibit-991005.jpg GRAPHIC 95442
9 GRAPHIC exhibit-991006.jpg GRAPHIC 24009
10 GRAPHIC exhibit-992001.jpg GRAPHIC 130993
11 GRAPHIC exhibit-992002.jpg GRAPHIC 117875
12 GRAPHIC exhibit-992003.jpg GRAPHIC 123876
13 GRAPHIC exhibit-992004.jpg GRAPHIC 108113
14 GRAPHIC exhibit-992005.jpg GRAPHIC 56110
  Complete submission text file 0001340243-23-000030.txt   1567026
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231120143
SIC: 2834 Pharmaceutical Preparations